Literature DB >> 10528875

Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.

K Stuertz1, H Schmidt, F Trostdorf, H Eiffert, M Mäder, R Nau.   

Abstract

In the rabbit model of Streptococcus pneumoniae meningitis, treatment with rifabutin, quinupristin-dalfopristin, moxifloxacin and trovafloxacin led to smaller increases of the CSF concentrations of the pro-inflammatory cell wall components lipoteichoic and teichoic acids (LTA and TA) than did treatment with ceftriaxone. Low doses of moxifloxacin were associated with higher LTA and TA concentrations in CSF than were high doses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528875     DOI: 10.1080/00365549950163806

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin.

Authors:  J Gerber; A Smirnov; A Wellmer; J Ragheb; J Prange; E Schütz; K Wettich; S Kalich; R Nau
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.

Authors:  Annette Spreer; Holger Kerstan; Tobias Böttcher; Joachim Gerber; Alexander Siemer; Gregor Zysk; Timothy J Mitchell; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

3.  Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis.

Authors:  Marija Djukic; Tobias Böttcher; Andreas Wellmer; Joachim Gerber; Viola V Brocke; Helmut Eiffert; Roland Nau
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 4.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Gemifloxacin is effective in experimental pneumococcal meningitis.

Authors:  A Smirnov; A Wellmer; J Gerber; K Maier; S Henne; R Nau
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Christian Schürch; Philippe Cottagnoud; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

Review 7.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

8.  Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.

Authors:  Joachim Gerber; Karin Pohl; Valeska Sander; Stephanie Bunkowski; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

9.  Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis.

Authors:  Tatiana Barichello; João Carlos Nepomuceno Gonçalves; Jaqueline S Generoso; Graziele L Milioli; Cintia Silvestre; Caroline S Costa; Jaqueline da Rosa Coelho; Clarissa M Comim; João Quevedo
Journal:  BMC Neurosci       Date:  2013-04-02       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.